Photodynamic therapy (PDT) is an anticancer approach utilizing a light-absorbing molecule and visible light irradiation to generate, in the presence of O 2 , cytotoxic reactive oxygen species, which cause tumor ablation. Given that the photosensitizer hypericin is under consideration for PDT treatment of bladder cancer we used oligonucleotide microarrays in the T24 bladder cancer cell line to identify differentially expressed genes with therapeutic potential. This study reveals that the expression of several genes involved in various metabolic processes, stress-induced cell death, autophagy, proliferation, inflammation and carcinogenesis is strongly affected by PDT and pinpoints the coordinated induction of a cluster of genes involved in the unfolded protein response pathway after endoplasmic reticulum stress and in antioxidant response. Analysis of PDT-treated cells after p38 MAPK inhibition or silencing unraveled that the induction of an important subset of differentially expressed genes regulating growth and invasion, as well as adaptive mechanisms against oxidative stress, is governed by this stress-activated kinase. Moreover, p38 MAPK inhibition blocked autonomous regrowth and migration of cancer cells escaping PDT-induced cell death. This analysis identifies new molecular effectors of the cancer cell response to PDT opening attractive avenues to improve the therapeutic efficacy of hypericin-based PDT of bladder cancer.
Introduction
Bladder cancer, the fourth most common malignancy in men and the ninth in women in the United States, is characterized by frequent recurrence and poor clinical outcome when tumors from noninvasive flat and papillary urothelial neoplasia progress to muscle invasive or metastatic disease (Sengupta et al., 2004) . Thus recognition of early-stage urothelial cancers and improvements in bladder cancer treatment are pressing needs. Photodynamic therapy (PDT) utilizes a tumor-localizing photosensitizer and visible light to produce reactive oxygen species (ROS) (Dolmans et al., 2003) . PDT efficacy relies on a combination of direct ROS-mediated cytotoxic effects, vascular damage and induction of inflammatory responses (Dolmans et al., 2003; Castano et al., 2006) , indicating a critical role for the molecular interplay between cancer cells and the surrounding tumor environment in therapeutic outcome.
Hypericin is a powerful photocytotoxic sensitizer with pronounced tumor-localizing properties (Kamuhabwa et al., 2004; Van De Putte et al., 2005) . We recently found that hypericin localizes in the neoplastic urothelium with higher specificity and selectivity to that displayed by aminolaevulinic acid, a precursor of the endogenous sensitizer protoporphyrin IX (D'Hallewin et al., 2002) . Thus, besides its exploitation for accurate fluorescent detection of these malignancies, hypericin may become the photosensitizer of choice for PDT of bladder cancer.
Previous studies showed that intracellularly, hypericin-PDT-induced cell death is mediated by endoplasmic reticulum (ER) Ca 2 þ store emptying and executed through caspase-dependent or -independent pathways (Buytaert et al., 2006) . However, hypericin-PDT also activates rescuing responses, chiefly governed by the activation of p38 MAPK (Assefa et al., 1999; Hendrickx et al., 2003) . p38 MAPK , of which four isoforms (p38-a, -b, -g and -d) exist, is a member of the mitogen-activated protein kinase (MAPK) superfamily commonly activated by cellular stress, proinflammatory cytokines and growth factors (Zarubin and Han, 2005) . Activated p38 MAPK orchestrates various cellular responses including inflammation and survival but in certain contexts also cell death (Zarubin and Han, 2005) . Recently, a tumor-promoting role for p38 MAPK in prostate cancer (Park et al., 2003) , breast cancer (Tsai et al., 2003; Suarez-Cuervo et al., 2004) , transformed follicular lymphoma (Elenitoba-Johnson et al., 2003; Lin et al., 2004) and leukemia (Liu et al., 2000) has emerged. This suggests that inhibition of this signaling pathway may become therapeutically attractive, especially for hypericin-PDT, since the survival role of p38 MAPK appears to be a distinguished molecular feature of this paradigm .
Given the emerging clinical possibility of hypericin-PDT (hereafter called 'PDT') for bladder cancer, we found of crucial relevance to increase our still limited knowledge of the global tumor responses to PDT since the identification of molecular elements of cell death and survival pathways is required to develop new and improved therapeutic strategies.
In this study, we utilize oligonucleotide microarrays to examine the stress response of human bladder cancer cells to PDT at the genome-wide level and show that a central molecular feature of this paradigm is the coordinated induction of transcripts involved in the regulation of ER stress, cell death, antioxidant response, inflammation and carcinogenesis. Additionally, this study shows that inhibition of p38-a and -b isoforms or p38 MAPK silencing repress an important subset of PDT-induced genes involved in inflammation, growth and invasion as well as antioxidant defense mechanisms. Finally, we provide a proof-of-concept that activation of the p38 MAPK signal transduction pathway increases tumorigenic potential of the surviving cancer cells after PDT.
Results

Global distribution of hypericin-PDT differentially expressed genes
To investigate molecular processes affected by PDT in T24 cells, we hybridized Affymetrix GeneChip HG-U133A 2. 0 arrays with biotinylated cRNA from control and PDT-treated T24 cells. We analysed two independent experiments performed in duplicate, generating four hybridizations per condition. We evaluated a 7 h postirradiation time point, associated with 20-30% apoptotic cell death, to correlate microarray data with expression of key-induced genes at the protein level and evaluate biological effects of p38 MAPK inhibition. Furthermore, two hybridizations from two independent experiments carried out 1 h postirradiation were also considered (data not shown), in order to single out early response genes (see Tables 1 and 2 ). Statistical filtering, retaining only genes with an increased or decreased expression of at least twofold and with an adjusted P-value o0.05, uncovered 826 genes significantly upregulated and 653 genes significantly downregulated by PDT, which were further annotated to Gene Ontology (GO) and subcategorized ( Figure 1a ). Of note, the class of metabolism and cell cycle/proliferation showed more genes repressed than upregulated, whereas the opposite was observed for genes involved in transcription and signal transduction ( Figure 1a ) (see Supplementary data for complete lists of differentially expressed genes ordered by biological process). The top 10-induced genes visualized in the M versus A plot included the inducible cyclooxygenase (COX)-2 (PTGS2), molecular chaperones (HSPA6, DNAJB9), stress-responsive genes (HMOX1, activating transcription factor (ATF)3, GDF15), a Ras-related GTPase involved in dynamic organization of cytoskeleton proteins (GEM) and genes implicated in extracellular matrix (ECM) remodeling and invasion (MMP1, MMP10, CSF2). The top 10-repressed transcripts included genes with tumor-promoting roles (ID3, SKP2, EDN1, ENC1, HOXA1, TGFB2) and genes involved in inflammation (CCL2), apoptosis (BCL2A1), G-protein signaling (RGS4) and cell-cell adhesion (PCDH7) (Figure 1b ).
Functional classification of hypericin-PDT-regulated genes and their p38
MAPK dependence Functional characterization of differentially regulated genes by PDT allowed subcategorization of transcripts participating in carcinogenesis and signaling pathways relevant to therapy outcome. Additionally, investigation of the transcriptome of PDT-treated T24 cells in the presence of PD169316, a specific inhibitor of p38 MAPK -a and -b, unraveled downstream targets of this stressactivated protein kinase. These genes are grouped in Tables 1 or 2 when belonging to a cluster of p38 MAPK -dependent genes.
Cell death modulators. An enriched class of upregulated genes consisted of heat shock protein (Hsps) family members (HSPA6, DNAJB9, HSPH1, SERPINH1, HSPD1, HSPCB), molecular chaperones known to regulate various adaptive intracellular responses allowing cell survival in stressful conditions (Calderwood et al., 2006) . Furthermore, a key feature of hypericin-PDT was the coordinated upregulation of proximal molecular sensors and effectors of the unfolded protein response (UPR) ( Table 1) , which is initiated by stress conditions perturbing ER homeostasis (Schroder and Kaufman, 2005) . Correspondingly, the protein kinase EIF2AK3 pancreatic ER kinase (PKR)-like ER kinase (PERK) and its downstream target eIF2a (eukaryotic translation initiation factor 2a) were induced. PhosphoeIF2a reduces protein load on the ER by stalling protein translation, while it paradoxically activates translation of certain mRNAs including that encoding for the transcription factor ATF4. Additionally, the ATF4 transcriptional targets DDIT3 (C/EBP homologous protein (CHOP)/GADD153) and PPP1R15A (Gadd34), which plays a role in translational recovery (Schroder and Kaufman, 2005) , were upregulated while CCND1, a known PERK target leading to G 1 cell cycle arrest, was concurrently downregulated. The differential expression of several transcripts with an established role in the PERK-eIF2a-ATF4 branch of the UPR required for CHOP expression is indicative of the validity of our microarray approach. Gene expression profiling of PDT-treated cancer cells E Buytaert et al UPR activation was further evidenced by the concurrent upregulation of XBP1 (X-box-binding protein 1), a transcription factor regulating various UPR-target genes including ER-resident chaperones (Schroder and Kaufman, 2005) . Interestingly, ATF3, a highly PDTinduced stress gene ( Figure 1b , Table 1 ) encoding a member of the ATF/cAMP-responsive element binding protein family of transcription factors, has been reported to be a PERK target (Jiang et al., 2004) , suggesting a link between ATF3 induction and ER stress in our paradigm. PDT also upregulated TRIB3, a downstream negative modulator of the CHOP/ATF4 pathway (Ohoka et al., 2005) , the ER protein HER-PUD1 which is involved in ER-associated degradation (ERAD), and SERP1, an ER translocon complex protein (Ma and Hendershot, 2004; Hori et al., 2006) .
Moreover, PDT affected the expression of several genes controlling the apoptotic process (Table 1) . Except for the induction of the inhibitor of apoptosis protein BIRC4 (XIAP), PDT mostly repressed the expression of many antiapoptotic genes including BCL2A1, BCL2 and BIRC5 (survivin). Also, death-associated protein kinase-related apoptosis-inducing kinase 2 (STK17B) and IkBa (NFKBIA) were significantly induced by PDT.
Remarkably, crucial genes involved in autophagy induction, including WIPI1 (human ortholog of the yeast autophagy-related gene (Atg)18), MAP1LC3B (human ortholog of the yeast Atg8) and ATG12 (Table 1) , were upregulated, thus suggesting that PDT increases the magnitude of the autophagic process.
Cell-cell interaction and ECM remodeling. Several transcripts regulating cell-cell and cell-matrix adhesion (PCDH7, THBS1, ITGB3, ICAM3, ICAM1), cell migration and cell-surface-mediated signal transduction (KITLG, ITGA2) and ECM remodeling (MMP1, MMP10, MMP13) were upregulated (Table 1) . After PDT, surviving T24 cells lost their ability to attach and grow on plastic plates (data not shown), and only attached and proliferated in collagen type I-coated plates. This indicates that photosensitization alters the cells' adhesive property and creates permissive conditions for cell attachment and persistence in collagen type I, a major component of the basal layer.
p38
MAPK -dependent targets. Pretreating T24 cells with PD169316 prior to irradiation led to the significant repression of 27 and induction of two genes when compared to PDT-treated cells in the absence of the inhibitor (Table 2 , see also 'Materials and methods' section). p38 MAPK inhibition affected the PDT-induced expression of immune and inflammatory response mediators, such as COX-2 (PTGS2), GM-CSF (granulocyte macrophage colony-stimulating factor; CSF2), interleukin 8 (IL8) and the Toll-like receptor 2, as also reported in previous studies (Hashimoto et al., 2000; Hoffmann et al., 2002; Imasato et al., 2002) . Notably, the expression of a number of stress-responsive genes encoding antioxidant and Phase II drug-metabolizing enzymes (Table 2) , with an established role in cellular protection following oxidative damage caused by ROS or electrophiles (Lee and Johnson, 2004 ) was found to be significantly attenuated by PD169316. This gene class, including HMOX-1, AKR1C1, AKR1C3, GCLC, GCLM, NQO1, TXNRD1, FTH1 and MT1X (Table 2) , is regulated by binding of transcription factor Nrf2 (NF-E2-related factor 2) to the antioxidant response element, a cis-acting regulatory element found in their promoter regions Lou et al., 2006) . Particularly, PD169316 suppressed coordinately, albeit to a different extent, the induction of AKR1C1, AKR1C3, GCLC and NQO1, suggesting that p38 MAPK activation stimulates Nrf2-dependent transcription following PDT. Moreover, p38
MAPK inhibition caused partial downregulation of superoxide dismutase SOD2 (Mn-SOD) induction, whose transcriptional activation through the Nrf2 pathway has not been reported so far.
Additional p38 MAPK -dependent transcripts included genes involved in transcriptional regulation (KLF11, PLAGL2, SIM2, CEBPD), metabolic pathways (ABCA1, INSR, DDAH2), chromatin remodeling (HIST1H2BG, HIST2H2AA), cell death (TNFRSF11B, STK3), cell-cell signaling (PTHLH, EREG), signal Abbreviations: ER, endoplasmic reticulum; CHOP, C/EBP homologous protein; PERK, pancreatic ER kinase (PKR)-like ER kinase; UPR, unfolded protein response; ATF, activating transcription factor; ECM, extracellular matrix; SERCA, sarco(endo)plasmic-reticulum Ca 2+ -ATPase; DAP, death-associated protein; NF-kB, nuclear factor-kB. Selected significantly (Po0.05) up-and downregulated genes in PDT-treated versus control T24 cells are presented according to biological process and ranked by fold change (FC) (as log 2 ratio). Genes detected upregulated 1 h after irradiation are marked in bold. Only genes with a log 2 ratio >|1| were included in the analysis, therefore genes presented with an induction below the threshold are indicated with 'y'. Transcripts involved in 'UPR' are indicated as such. Abbreviations: ECM, ; extracellular matrix; TNF, tumor necrosis factor. Selected significantly (Po0.05) upregulated genes in PDT-treated versus control T24 cells are presented according to biological process and ranked by fold change (FC) (as log 2 ratio). p38 MAPK dependence (up-or downregulation by 1 mM PD169316 as shown by the arrows) is indicated as percentage (%) of differential gene expression of PDT-treated versus control T24 cells. Genes detected upregulated 1 h after irradiation are marked in bold. Only genes with a log 2 ratio >|1| were included in the analysis, therefore genes presented with an induction or decrease below the threshold are indicated with 'y'.
Gene expression profiling of PDT-treated cancer cells E Buytaert et al transduction (RGL1, CLCF1), development/differentiation/growth (RELN) and cell adhesion (CLDN14). Of note, p38 MAPK was required for the PDT-mediated upregulation of the ECM remodeling gene MMP13. The expression of relevant cell death modulators, including CHOP and Gadd34, as well as some p38 MAPK -regulated genes, such as COX-2 and IL-8, was affected early after PDT (for example, 1 h), suggesting that these targets contribute to the early cellular responses induced by PDT.
Validation of the microarray results by real-time quantitative PCR and western blotting To verify PDT-mediated changes in transcript levels detected by microarray analysis, we performed qRT-PCR for a selection of relevant differentially expressed genes, which were strongly upregulated by PDT (MMP1, MMP10, HMOX1) and significantly inhibited by PD169316 (MMP13, AKR1C1). Fold changes from qRT-PCR of all genes analysed in T24 cells correlated well with microarray analysis results (Figure 2a) . Moreover, in conformity with the microarray data (Table 2) , MMP13 and AKR1C1 upregulation after PDT in T24 cells was virtually abolished in the presence of PD169316. Although not evidenced by the microarray analysis (Table 2) , PD169316 attenuated HMOX1 induction by PDT (Figure 2a) . To validate the general relevance of the results obtained with T24 cells, qRT-PCR of the selected genes was also performed in the low-grade, papillary bladder cancer cell line RT4. In PDT-treated RT4 cells, mRNA induction of MMP1 and MMP10 correlated well with the qRT-PCR results of T24 cells (Figure 2a) , although in general mRNA induction in RT4 cells was somehow lower at 7 h after PDT. The induction of MMP13, HMOX1 and AKR1C1 in RT4 cells was also strongly p38 MAPK dependent (Figure 2b) , thus extending the significance of the identified molecular targets to Western blotting was performed to test whether microarray results accurately predicted changes in protein expression. Five highly induced genes (PTGS2, HMOX1, AKR1C1, DDIT3, HSPA6) covering key PDT-regulated biological processes were examined. Unfortunately, the poor specificity of commercially available matrix metalloproteinase (MMP) antibodies prevented accurate protein expression analysis of these PDT targets. ATP2A2, the sarco(endo)plasmic-reticulum Ca 2 þ -ATPase (SERCA) and BCL2 were taken as paradigms of PDT downregulated genes (Table 1) .
Directional changes in protein expression were consistent with the differential PDT effect on corresponding transcripts as determined by microarray analysis of the T24 cells. COX-2 and AKR1C1 protein expression levels, but not Hsp70, were strongly repressed in the presence of PD169316 (Figure 3a , left panels), which clearly inhibited p38 MAPK activity (Figure 3c ). Moreover, specific effects of PD169316 were confirmed by p38 MAPK siRNA knockdown, which dramatically affected the induction of COX-2, a key p38 MAPK target (Figure 3d ). PD169316-repressed heme oxygenase 1(HO-1) and surprisingly also CHOP induction by PDT at the protein level (Figure 3a , left panels), to an extent unpredictable from qRT-PCR (Figure 2a) or evidenced by microarray analysis ( Table 2) .
The increase in protein levels of the main targets HO-1, COX-2, Hsp70, as well as the decline of SERCA2 and Bcl-2 proteins after hypericin-PDT in RT4 (Figures 3a  and b , right panels) and in the invasive bladder cancer J82 cells (data not shown), were consistent with the pattern observed in T24 cells. Also the data on the p38 MAPK dependence were largely similar in all bladder cancer cells examined. A notable exception was CHOP whose induction after PDT in RT4 (Figure 3a , right panel) and J82 cells (data not shown) was not affected by PD169316, implying a cell line-specific regulation of this ER stress effector. The PDT-mediated induction of the AKR1C1 protein was reduced in the RT4 and J82 cells as compared to the T24 cells. However, slight but consistent p38 MAPK -dependent stimulation in the AKR1C1 protein level in response to PDT could be still detected in the RT4 cells (Figure 3a , right panel).
MAPK is required for growth and migratory capacity of the PDT-surviving cells Given the established role of several p38 MAPK -dependent transcripts in carcinogenesis, we investigated the longterm biological relevance of p38 MAPK inhibition on growth and migration of T24 cells surviving PDT. T24 cells were PDT treated in the presence or absence of PD169316 and 24 h after irradiation of the apoptotic cells, as revealed by active/processed caspase-3 (data not shown), were separated from the surviving cell fraction. The proliferation capacity of the surviving cells was monitored during several days, after replating them in 0.5% fetal calf serum (FCS) containing medium ('basal medium') or in their own medium (medium collected 24 h after PDT: 'conditioned medium'). Although the surviving cells cultured in basal medium were initially unable to proliferate, they dramatically regained their proliferation capacity in time (12 days) (Figures 4a and  b, upper right panel) , indicating an autocrine ability to growth in low serum conditions. Surviving cells cultured in their own PDT-conditioned medium maintained their proliferation capacity throughout, indicating that this medium is enriched in factors required for their proliferation. Importantly, PD169316 completely abolished this growth competence (Figures 4a and b , upper right panel), strongly suggesting that the release of growth-promoting factors depends on the activation of the p38 MAPK signaling cascades.
Subsequently, we evaluated the proliferation of control T24 cells cultured in 'basal medium' or in PDTconditioned medium. Control cells readily proliferated reaching confluency after 12 days when cultured in conditioned medium (Figures 4a and b, upper left panel) . This indicates that PDT-treated cells release factors able to stimulate in a paracrine way the proliferation of neighboring, nonaffected cells. Conversely, control cells ceased to proliferate when cultured in basal medium or in Figure 4 p38MAPK plays a key role in growth and migration of T24 cells surviving photodynamic therapy (PDT)-treatment. T24 cells were PDT treated in 0.5% FCS DMEM. 1 mM PD169316 was added 1 h prior to irradiation, where indicated. Cells used in the migration assay were kept in 0.5% FCS DMEM for 24 h prior to irradiation. (a) Proliferation of control and surviving PDT-treated T24 cells (SC) (24 h after irradiation), in the absence or presence of PD169316, was assayed as described in 'Materials and methods' section. Medium from control cells is indicated 'basal medium', whereas 'conditioned medium' is collected from PDT-treated cells, with or without PD169316 as indicated. Representative light microscopic pictures were taken from cells visualized with 0. conditioned medium derived from PDT-treated cells in the presence of PD169316. The addition of PD169316 to the basal medium did not significantly affect the proliferation capacity of control T24 cells, thus ruling out a direct effect of this inhibitor on cell growth (Figure 4b, lower panel) .
Next, we evaluated the migratory potential of the surviving PDT-treated T24 cells and the impact of PD169316 on this tumor-promoting process (Figure 4c) . A similar number of control or PDT-treated T24 cells, in the absence or presence of PD169316, were subjected to a transwell migration assay 24 h after PDT. Note that within the first day the growth rate of surviving PDT-treated and control cells did not vary significantly (Figure 4b , upper panels), thus measurable differences in migration cannot be explained by differences in the amount of cells at the time of the migration detection (12 h). Although at this postirradiation time point the PDT-treated cancer cells exhibited an attenuated pro-migratory ability as compared to control T24 cells, their migration was critically inhibited by PD169316 (Figure 4c ).
Discussion
Using oligonucleotide microarray analysis, we unraveled the coordinated expression of a gene cluster involved in cell death regulation after hypericin-PDT and additionally identified new p38 MAPK -dependent targets and signaling pathways. This approach was not explored in previous studies with other photosensitizers (Verwanger et al., 2002; Makowski et al., 2003; Wild et al., 2005) which utilized more restricted microarray platforms, thereby analysing the global PDT responses on a limited gene set.
Our analysis reveals a coordinated upregulation by PDT of several Hsp family members of molecular chaperones involved in cytoprotection (Calderwood et al., 2006) and transcripts implicated in the UPR. PDT induced different molecular UPR components; induction of genes encoding ER-resident chaperones to assist correct protein folding (through XBP-1), translational attenuation to alleviate protein load on the ER (through the PERK-eIF2a-ATF4 pathway) and ERAD to degrade ER-accumulated unfolded proteins (through HERPUD1) (Schroder and Kaufman, 2005) . Since the most apical biochemical event in hypericin-photosensitized cells is the fast ER Ca 2 þ depletion induced by SERCA photooxidation (Buytaert et al., 2006) , our data suggest that ER perturbations caused by the accumulation of photooxidized/misfolded proteins can persistently activate the UPR pathway.
Cell fate following ER stress and UPR induction is not fully understood, but increasing evidence indicates that this pathway is used to induce both adaptive and cell death responses and could affect tumor growth, promote dormancy and influence therapy outcome (Ma and Hendershot, 2004) . Intriguingly, parallel to UPR induction hypericin-PDT induces Atgs ( Table 1 ), suggesting that this cellular degradation process may be initiated to reestablish ER homeostasis following photodamage. This is supported by recent studies pointing to ER stress as a powerful inducer of autophagy (Ogata et al., 2006; Yorimitsu et al., 2006) . Recently we have shown that autophagy induced by hypericin-PDT in mouse embryonic fibroblasts under apoptosis-deficient conditions (for example, Bax/Bak double knockout) turns into a lethal pathway (Buytaert et al., 2006) , possibly due to increased persistence in the absence of caspase signaling. However, more studies are required to understand the role of autophagy and its relationship with the UPR in apoptosis-competent cells.
When ER stress is persistent and insolvable, sustained UPR leads to cell death, which can be mediated through CHOP-dependent targets (Marciniak et al., 2004; Szegezdi et al., 2006) . PDT-mediated apoptosis with a mitochondrial-and ER-localizing porphyrin was shown to be attenuated in chop-deficient cells (Wong et al., 2004) . Thus, CHOP expression may contribute to efficient apoptosis induction by PDT initiated by ER photodamage and it is tempting to speculate that repression of Bcl-2 expression (Table 1 and Figure 3b ) by hypericin-PDT in bladder cancer cells may result from CHOP activation and is mechanistically involved in photo killing.
This study further reveals key cellular PDT-responses critically influenced by the p38 MAPK pathway. The pleiotropic p38 MAPK appears to contribute to carcinogenesis by regulating growth factor expression (Elenitoba-Johnson et al., 2003; Tsai et al., 2003; Lin et al., 2004) , inflammatory- (Park et al., 2003) , and invasion-associated genes, including members of the MMP family (Johansson et al., 2000; Reunanen et al., 2002; Suarez-Cuervo et al., 2004; Huang et al., 2005) .
Our results confirm the crucial role of p38 MAPK in modulating immune and inflammatory responses by upregulation of for example, COX-2, IL8 and CSF2, and additionally assign novel important molecular functions to this pathway in PDT signaling. Accordingly, we show the p38 MAPK -coordinated induction by PDT of selected genes encoding 'phase 2 enzymes' including AKR1C1, AKR1C3, GCLC, NQO1 (Table 2 and Figure 2 ) as well as HMOX1 (Figures 2 and 3) . These cytoprotective genes are induced by oxidants and electrophilic carcinogens through activation of the redox-dependent Keap1/Nrf2 pathway (Itoh et al., 1999; Lee and Johnson, 2004) . Accordingly, we recently observed that the activation of PI3K and p38 MAPK signaling pathways by PDT contributes to HO-1 protein induction and survival through a mechanism involving nuclear accumulation of Nrf2 (Kocanova et al., 2007) . Thus p38 MAPK may indeed attenuate oxidative stress following PDT through the regulation of the Nrf2/ Keap1 system. Furthermore our study reveals that MMP-13, a member of the collagenase subfamily of MMPs, is a p38 MAPK target. MMP-13 is expressed at the invading edges of urinary bladder transitional cell carcinoma (TCC) in vivo, and is regulated in vitro in T24 cells stimulated by tumor necrosis factor-a (TNF-a) through p38
MAPK (Bostrom et al., 2000) . (Espel, 2005) . Thus, the p38 MAPK pathway in PDT-treated T24 cells could rapidly stabilize and increase translation of AREs-containing labile mRNAs, for example, for MMP-13, COX-2 and GM-CSF, involved in tumor promotion (Hashimoto et al., 2000; Hoffmann et al., 2002; Dean et al., 2004) .
The p38 MAPK -dependent PDT-induced CHOP expression in T24 cells (Figure 3a , left panel) is intriguing, as it points to regulation of cell death modulators of the ER stress pathway. CHOP can be post-translationally activated by p38
MAPK through phosphorylation at Ser78 and Ser81 (Wang and Ron, 1996) and a p38 MAPK antagonist represses peroxynitrite-induced CHOP mRNA and protein expression (Oh-Hashi et al., 2001) . Since CHOP induction has been linked to cell death following prolonged ER stress, the p38 MAPK pathway could paradoxically also induce the expression of cell death modulators after PDT. However, the p38 MAPK inhibitor effect on CHOP protein expression appears to depend on the bladder cancer cell line examined ( Figure 3b ) and further studies linking p38 MAPK activation to ER stress-induced CHOP activation and cell death are required.
This study unquestionably shows that supporting a cancer-prone phenotype is a major long-term biological function of the PDT-activated p38 MAPK pathway. This notion is based on the evidence that p38
MAPK not only drives regrowth and supports migration of 'undead' cells after PDT, but also enforces in a paracrine fashion the growth of nonaffected cancer cells.
Although orchestrates the induction of several genes involved in carcinogenesis, it is tempting to speculate that one of its major downstream effectors may be the release of soluble COX-2 metabolites (for example, prostaglandin (PG)E 2 ). A recent study in human T cells shows that a PGE 2 -mediated stimulation of p38 MAPK is involved in IL-8 transcription (Caristi et al., 2005) through CHOP activation, raising the intriguing possibility that a PGE 2 -dependent positive feedback could maintain p38 MAPK signaling and stimulate secondary responses dependent on this pathway. Thus, the role of p38 MAPK -COX-2-PGE 2 cascade in the modulation of tumor growth as well as the immune response in vivo deserves to be further addressed.
Materials and methods
Materials
Hypericin was purified and stored as in Hendrickx et al., 2003 . Cell culture products were from Cambrex (Verviers, Belgium) and FCS from Perbio Hyclone (Erembodegem, Belgium). Antibodies were purchased from Biomol Research Laboratories (Plymouth, PA, USA) (anti-caspase-3), Santa Cruz (Santa Cruz, CA, USA) (anti-COX-2, -Hsp70, -HO-1, -CHOP), Abnova (Taipei, Taiwan) (anti-AKR1C1), Pharmingen (San Diego, CA, USA) (anti-Bcl-2) and Sigma (Saint Louis, MO, USA) (anti-atubulin). The SERCA2b antibody was kindly provided by Dr F Wuytack (KULeuven, Belgium). Secondary antibodies were from DAKO (Glostrup, Denmark). PD169316 was from Calbiochem (San Diego, CA, USA).
Cell culture, photosensitization and siRNA transfection T24 and RT4 cells (human TCC of the bladder) were preincubated with 150 nM hypericin for 16 h in subdued light conditions (o1 mW cm À2 ) followed by irradiation (4 J cm
À2
) in Dulbecco's modified Eagle's medium (DMEM) ('PDT-treated') as described (Hendrickx et al., 2003) . 'Controls' are cells preincubated with 150 nM hypericin, but not subsequently irradiated. Total cell lysates were prepared (Buytaert et al., 2006) (Kocanova et al., 2007) .
Affymetrix microarrays
Total RNA was isolated using the RNeasy Mini kit (Qiagen) from two independent experiments performed in duplicate generating four hybridizations per sample. RNA quality and concentration was determined using Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). Samples were prepared for microarray hybridization on Affymetrix GeneChip HG-U133A 2.0 arrays, according to the manufacturer's instructions (Affymetrix, Santa Clara, CA, USA).
Analysis of microarrays
Microarray data preprocessing and analysis was performed using Bioconductor software implemented in the statistical programming environment R. The data, containing four samples (control T24 cells and PDTtreated T24 cells at 7 h after irradiation, each in the presence and absence of PD169316) and four repeats of each sample, were normalized using the GC Robust Multi-array Average (GCRMA) method (Wu et al., 2004) . MAS5.0 present/absent calls were calculated and features with over 13 out of 16 absent calls were regarded as not expressed in the whole experiment and removed from further analysis. After filtering, 14 488 features remained. Subsequently differential expression was determined using the linear models method implemented in the limma package. Obtained P-values were adjusted for multiple testing using the false discovery rate-based P-value adjustment (Benjamini and Hochberg, 1995) . Threshold for differential expression was o0.05 on the adjusted P-values. Comparison of the gene expression profiles in control cells with or without PD169316 indicated that the inhibitor by itself had a negligible impact as it resulted in the differential expression of only one gene (SERPINA1 fold change: 1.96, P ¼ 0.008). Selected differential expressed genes were annotated with GO identifiers using the biomaRt package (Durinck et al., 2005) , which retrieves data from Ensembl (Birney et al., 2006) . These GO terms were mapped to the generic GO slim available from the GO website (http://www.geneontology.org). Actual mapping was performed using the map2slim Perl script, also available from the GO website.
Real-time quantitative PCR cDNA was prepared in a 20 ml final volume with 1 mg RNA as described (Volanti et al., 2004) . cDNA (2 ml) was mixed with 10 ml SYBR Green Mix (Applied Biosystems, Warrington, UK) and forward and reverse primers for each gene of interest, or with 300 nM forward (5 0 -GAGTATGCCTGCCGTGTG-3 0 ) and 300 nM reverse (5 0 -AATCCAAATGCGGCATCT-3 0 ) b2-microglobulin (B2M) primers in a 20 ml final volume. Realtime PCR was performed with the ABI-PRISM 7000 Sequence Detection System (Applied Biosystems). Data were subjected to relative quantification using the comparative C T (DDC T ) method, where B2M was used as an endogenous reference for normalization. The following arithmetic formula was applied to each sample, and the results plotted in fold induction: 
Proliferation and migration assays
Prior to irradiation, T24 cells were washed with phosphatebuffered saline and replaced in DMEM containing 0.5%. FCS, with or without PD169316 as detailed in figure legends. After 24 h of irradiation, control and surviving PDT-treated cells were collected, resuspended in basal or different conditioned media as indicated and replated either in collagen I-coated 96-well plates (0.005 Â 10 6 cells per well) or in the upper chamber of transwells (20 Â 10 3 cells) for proliferation or migration assays, respectively.
Proliferation assay Proliferation assay at indicated time points after replating and cell proliferation was measured by naphthol blue black (NBB) (Acros Organics, Geel, Belgium) assay. Briefly, cells were fixed in 10% formaldehyde for 10 min, washed and incubated with 0.05% NBB for 30 min at 37 1C. After washing, NBB was eluted with 50 mM NaOH for 1 h at room temperature, and absorbance was measured at 630 nm.
Migration assay Migration of control or surviving PDTtreated T24 cells was analysed through polycarbonate filters (8 mm pore size) (Elscolab, Kruibeke, Belgium) coated with type I collagen (BD Biosciences, Bedford, MA, USA) (modified Boyden chamber). Medium (10% FCS) was placed in the lower chamber as chemoattractant. Following a 12 h incubation period, nonmigrated cells on the upper surface of the filter were removed, and the cells migrated through the filter were fixed, washed and counted manually by fluorescence microscopy after visualizing cell nuclei with 4 0 6-diamidino-2-phenylindol -containing Vectashield mounting medium (Vector, Burlingame, CA, USA).
Abbreviations
AREs, adenylate/uridylate-rich elements; ATF, activating transcription factor; Atg, autophagy-related gene; CHOP, C/EBP homologous protein; COX-2, cyclooxygenase-2; ECM, extracellular matrix; ER, endoplasmic reticulum; ERAD, ER-associated degradation; GO, Gene Ontology; GM-CSF, granulocyte macrophage colony-stimulating factor; HO-1, heme oxygenase 1; Hsp, heat shock protein; MAPK, mitogen-activated protein kinase; MMP, matrix metalloproteinase; Nrf2, NF-E2-related factor 2; PDT, photodynamic therapy; PG, prostaglandin; PERK, pancreatic ER kinase (PKR)-like ER kinase; ROS, reactive oxygen species; SERCA, sarco(endo)plasmic-reticulum Ca 2 þ -ATPase; TCC, transitional cell carcinoma; UPR, unfolded protein response.
